Telix pharmaceutical/$TLX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Telix pharmaceutical

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Ticker

$TLX
Sector
Primary listing

Employees

423

Headquarters

North Melbourne, Australia

TLX Metrics

BasicAdvanced
$3.7B
256.10
$0.04
2.28
-

Bulls say / Bears say

The FDA has requested additional data on Telix’s kidney cancer imaging drug Zircaix because of deficiencies in manufacturing and supply chain, postponing its U.S. approval and commercial launch plans (Reuters).
Telix shares dropped as much as 24% in early trading and closed nearly 19% lower on the ASX following the FDA’s request, marking the stock’s steepest single-day decline to date and highlighting serious investor concerns about regulatory obstacles (Reuters).
Telix has a trailing P/E of around 337x and trades at approximately 146x price-to-cash flow, which signals high valuation risk should its commercial execution or drug pipeline fail to meet expectations (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TLX

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events
FAQs